In order to make the greatest impact, patients and advocates need a complete knowledge and understanding of the drug development process. That’s why, in partnership with Friends of Cancer Research, Phase One is pleased to be able to offer a new course and tool for patient advocates - Through the Advocacy Education program, advocates will acquire the necessary tools to effectively communicate with drug researchers, developers, and regulators enabling them to make the connections necessary to engage with all sectors who need to be better guided by patient input.   To get more information and gain access to the Advocacy Education Program, click below.